发明名称 |
High drug load tablet |
摘要 |
The present invention pertains to a high drug load tablet comprising an active ingredient Compound I of formula;
or a pharmaceutically acceptable salt thereof in an amount from about 30% to 80% in weight of the active moiety based on the total weight of the tablet. |
申请公布号 |
US9011911(B2) |
申请公布日期 |
2015.04.21 |
申请号 |
US201414162237 |
申请日期 |
2014.01.23 |
申请人 |
Novartis AG |
发明人 |
Luftensteiner Christian-Peter;Bianchi Jean-Claude;Ogorka Joerg;Kalb Oskar |
分类号 |
A61K9/20;A61K9/28;A61K31/497;A61K31/505;A61K31/185;A61K31/506;B29C43/00 |
主分类号 |
A61K9/20 |
代理机构 |
|
代理人 |
Mulkeen Matthew |
主权项 |
1. A small tablet comprising a pharmacologically effective amount of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of formula (1) in the form of a monomesylate salt as the sole active drug: in an amount from 30% to 80% by weight of the active moiety based on the total weight of the small tablet; and 10 to 35% by weight of at least one disintegrant based on the weight of the small tablet, wherein the at least one disintegrant is cross-linked polyvinlypyrrolidinone, wherein the small tablet is either a small ovaloid tablet that is 10 to 20 mm in length, 5 to 10 mm in width and 4 to 8 mm in thickness or a small round tablet that is 5 to 15 mm in diameter and 2 to 5 mm in thickness and wherein the pharmacologically effective amount of the sole active moiety 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide is from 50 mg to 600 mg. |
地址 |
Basel CH |